These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 18552820

  • 1. Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system.
    Su MC, Yuan RH, Lin CY, Jeng YM.
    Mod Pathol; 2008 Nov; 21(11):1379-86. PubMed ID: 18552820
    [Abstract] [Full Text] [Related]

  • 2. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2.
    Panarelli NC, Yantiss RK, Yeh MM, Liu Y, Chen YT.
    Am J Clin Pathol; 2012 Aug; 138(2):211-22. PubMed ID: 22904132
    [Abstract] [Full Text] [Related]

  • 3. Claudin-18 as a Marker for Identifying the Stomach and Pancreatobiliary Tract as the Primary Sites of Metastatic Adenocarcinoma.
    Li WT, Jeng YM, Yang CY.
    Am J Surg Pathol; 2020 Dec; 44(12):1643-1648. PubMed ID: 32925194
    [Abstract] [Full Text] [Related]

  • 4. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
    Bayrak R, Haltas H, Yenidunya S.
    Diagn Pathol; 2012 Jan 23; 7():9. PubMed ID: 22268990
    [Abstract] [Full Text] [Related]

  • 5. Cadherin 17 is a novel diagnostic marker for adenocarcinomas of the digestive system.
    Ordóñez NG.
    Adv Anat Pathol; 2014 Mar 23; 21(2):131-7. PubMed ID: 24508695
    [Abstract] [Full Text] [Related]

  • 6. Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers.
    Rao Q, Williamson SR, Lopez-Beltran A, Montironi R, Huang W, Eble JN, Grignon DJ, Koch MO, Idrees MT, Emerson RE, Zhou XJ, Zhang S, Baldridge LA, Cheng L.
    Mod Pathol; 2013 May 23; 26(5):725-32. PubMed ID: 23348900
    [Abstract] [Full Text] [Related]

  • 7. Altered expression of E-cadherin in gastric cancer tissues and carcinomatous fluid.
    Matsuura K, Kawanishi J, Fujii S, Imamura M, Hirano S, Takeichi M, Niitsu Y.
    Br J Cancer; 1992 Dec 23; 66(6):1122-30. PubMed ID: 1333788
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical studies on the localization of cancer associated antigens DU-PAN-2 and CA19-9 in carcinomas of the digestive tract.
    Ohshio G, Ogawa K, Kudo H, Yamabe H, Nakashima Y, Kim YC, Endo K, Watanabe Y, Manabe T, Tobe T.
    J Gastroenterol Hepatol; 1990 Dec 23; 5(1):25-31. PubMed ID: 2103381
    [Abstract] [Full Text] [Related]

  • 9. Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study.
    Villari D, Caruso R, Grosso M, Vitarelli E, Righi M, Barresi G.
    Pathology; 2002 Oct 23; 34(5):423-6. PubMed ID: 12408340
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.
    Wang HL, Lu DW, Yerian LM, Alsikafi N, Steinberg G, Hart J, Yang XJ.
    Am J Surg Pathol; 2001 Nov 23; 25(11):1380-7. PubMed ID: 11684954
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical analysis of E-cadherin expression in human colorectal tumours.
    Van Aken J, Cuvelier CA, De Wever N, Roels J, Gao Y, Mareel MM.
    Pathol Res Pract; 1993 Nov 23; 189(9):975-8. PubMed ID: 8302730
    [Abstract] [Full Text] [Related]

  • 12. T-complex-associated-testis-expressed 3 (TCTE3) is a novel marker for pancreatobiliary carcinomas.
    Zhao CL, Hui Y, Wang LJ, Lombardo K, Yang D, Mangray S, Yakirevich E, Amin A, Huang CK, Lu S.
    Hum Pathol; 2017 Dec 23; 70():62-69. PubMed ID: 29079176
    [Abstract] [Full Text] [Related]

  • 13. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
    Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT.
    Am J Surg Pathol; 2016 Mar 23; 40(3):419-32. PubMed ID: 26551622
    [Abstract] [Full Text] [Related]

  • 14. CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2.
    Altree-Tacha D, Tyrrell J, Haas T.
    Arch Pathol Lab Med; 2017 Jan 23; 141(1):144-150. PubMed ID: 28029907
    [Abstract] [Full Text] [Related]

  • 15. [E-cadherin molecular expresion in the diffuse and intestinal types of gastric adenocarcinoma. A report from Lima, Peru].
    Arévalo F, Monge E, Morales D.
    Rev Esp Enferm Dig; 2007 Jun 23; 99(6):325-9. PubMed ID: 17883295
    [Abstract] [Full Text] [Related]

  • 16. Use of E-cadherin and CD44 aids in the differentiation between reactive mesothelial cells and carcinoma cells in pelvic washings.
    Chhieng DC, Yee H, Cangiarella JF, Symmans WF, Cohen JM.
    Cancer; 2000 Oct 25; 90(5):299-306. PubMed ID: 11038427
    [Abstract] [Full Text] [Related]

  • 17. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
    Oue N, Mitani Y, Aung PP, Sakakura C, Takeshima Y, Kaneko M, Noguchi T, Nakayama H, Yasui W.
    J Pathol; 2005 Oct 25; 207(2):185-98. PubMed ID: 16086444
    [Abstract] [Full Text] [Related]

  • 18. Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumors.
    Jacobsen F, Pushpadevan R, Viehweger F, Freytag M, Schlichter R, Gorbokon N, Büscheck F, Luebke AM, Putri D, Kluth M, Hube-Magg C, Hinsch A, Höflmayer D, Fraune C, Bernreuther C, Lebok P, Sauter G, Minner S, Steurer S, Simon R, Burandt E, Dum D, Lutz F, Marx AH, Krech T, Clauditz TS.
    Pathol Res Pract; 2024 Apr 25; 256():155175. PubMed ID: 38452580
    [Abstract] [Full Text] [Related]

  • 19. Expression of E- and P-cadherin in gastric carcinomas.
    Shimoyama Y, Hirohashi S.
    Cancer Res; 1991 Apr 15; 51(8):2185-92. PubMed ID: 2009537
    [Abstract] [Full Text] [Related]

  • 20. HNF6 and HNF4α expression in adenocarcinomas of the liver, pancreaticobiliary tract, and gastrointestinal tract: an immunohistochemical study of 480 adenocarcinomas of the digestive system.
    Toriyama K, Uehara T, Iwakoshi A, Kawashima H, Hosoda W.
    Pathology; 2024 Oct 15; 56(6):804-813. PubMed ID: 38926048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.